Eric Shaff Net Worth (2024) | Wallmine

Eric Shaff biography

Eric D. Shaff serves as President, Chief Executive Officer, Director of the Company. Previously, he served as our Chief Operating and Financial Officer and Executive Vice President from January 2018 until January 2019 and as our Chief Financial Officer from November 2014 until January 2019. Mr. Shaff has also served on the board of directors of Sigilon Therapeutics, Inc. since November 2017. From January 2012 to November 2014, Mr. Shaff was Vice President of Corporate Finance for Momenta Pharmaceuticals (“Momenta”), a biotechnology company, where he helped manage Momenta’s accounting, finance, planning, and procurement functions, as well as contributing to Momenta’s investor relations efforts. From June 2004 to December 2011, Mr. Shaff held a number of corporate development and finance positions with Genzyme Corporation, a biotechnology company, most recently as Vice President of Finance/Controller for the Personalized Genetic Health division. Mr. Shaff received his B.A. from the University of Pennsylvania and his M.B.A. from Cornell University.

What is the salary of Eric Shaff?

As the President, Chief Executive Officer, and Director of Seres Therapeutics Inc, the total compensation of Eric Shaff at Seres Therapeutics Inc is $2,032,550. There are no executives at Seres Therapeutics Inc getting paid more.